Safety and efficacy of PD-1/PD-L1 inhibitors combined with albumin-bound paclitaxel and fluorouracil-based agents as second-line therapy in biliary tract cancers. - Wang X; Zha Y; Li P; Fu S; Xu L; Jiang W; Wu J; Mao Y (World journal of surgical oncology, 2026)